Catheter-related deep venous thrombosis in children with hemophilia

Slides:



Advertisements
Similar presentations
A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in.
Advertisements

JAK2V617F mutation for the early diagnosis of Ph − myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis by Francesco Dentali,
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome by Bart.
Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Venous Thromboembolism Prophylaxis in Pediatric Patients With Central Venous.
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis by Marcello Di Nisio, Anne W. S. Rutjes, Noemi.
Generating AML-Specific Peripheral Blood Autologous Cytotoxic T-Lymphocytes (CTLs)‏ by Rohtesh S. Mehta, Xiaohua Chen, Antony Jeyaraj, and Paul Szabolcs.
An algorithm for the management of primary subclavian vein thrombosis
Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis  Timothy K. Liem, MD, Keenan E. Yanit,
Massive Upper GI Bleeding in a Long-term Hemodialysis Patien
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
M. Kim, H. Kwon, S. -K. Hong, Y. Han, H. Park, J. Y. Choi, T. -W
UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER
Central venous line–related thrombosis in children: association with central venous line location and insertion technique by Christoph Male, Peter Chait,
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis by Paolo Prandoni,
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use by Ida Martinelli, Anthonie W. A. Lensing, Saskia.
TCR-MHC-peptide(s): in vivo veritas
Autologous stem cell transplantation followed by a dose-reduced allograft induces high complete remission rate in multiple myeloma by Nicolaus Kröger,
Next-generation leukemia immunotherapy
In utero transplantation may soon be in delivery
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology by Mary Cushman,
Tax fingerprint in adult T-cell leukemia
How I treat elderly patients with myeloma
Nonmyeloablative conditioning for relapsed follicular lymphoma
Symptomatic and Incidental Venous Thromboembolic Disease Are Both Associated With Mortality In Patients With Prostate Cancer by Shruti Chaturvedi, Surbhi.
Epistaxis as a Rare Complication of Catheter-Related Central Venous Stenosis  Jin-Ju Tsai, MD, Ching-Chih Hsia, MD, Dong-Ming Tsai, MD, Wei-Tsung Chen,
Autologous Transplantation Therapy for Chronic Myelogenous Leukemia
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children by Ayami Yoshimi, Charlotte.
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute.
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein.
by Jessica A. Reese, Xiaoning Li, Manfred Hauben, Richard H
An actuarial GPS for hemophilic longevity
Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein.
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
Symptomatic venous thromboembolism after femoral vein harvest
Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk.
Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,
Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis  Timothy K. Liem, MD, Keenan E. Yanit,
Symptomatic ileofemoral DVT after onset of oral contraceptive use in women with previously undiagnosed May-Thurner Syndrome  Erin H. Murphy, MD, Charles.
Surgical thrombectomy for iliofemoral venous thrombosis revisited
How I treat cancer-associated venous thromboembolism
Schematic overview of the Borden system of classification for DAVFs
The patterns and distribution of residual abnormalities between the individual proximal venous segments after an acute deep vein thrombosis  Ann M. O'Shaughnessy,
Internal jugular to axillary vein bypass for subclavian vein thrombosis in the setting of brachial arteriovenous fistula  John D. Puskas, MD, Jonathan.
Stenting of proximal venous obstructions to maintain hemodialysis access  Richard Shoenfeld, MD, Howard Hermans, MD, Andrew Novick, MD, Bruce Brener, MD,
Streptokinase in the treatment of subclavian vein thrombosis
Limited B-mode venous imaging versus complete color-flow duplex venous scanning for detection of proximal deep venous thrombosis  Roberta Poppiti, BS,
Blood Disorder: Hemophilia
Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.
Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin by Sarah L. Reeves, Hannah K. Jary, Jennifer.
by Wendy Lim, Sara K. Vesely, and James N. George
Representative images of coronary angiography and fractional flow reserve (FFR) from a patient who showed no resting ECG abnormality. Representative images.
Erratum in Ledru et al. Alteration of tumor necrosis factor–α T-cell homeostasis following potent antiretroviral therapy: contribution to the development.
Volume 2(Supplement 1):39-41
Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein.
Jay B. Fisher, MD, Marc A. Granson, MD  Journal of Vascular Surgery 
Two-staged stent implantation for multiple supra-aortic lesions
American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism by Wendy Lim, Grégoire Le.
Rituximab immunotherapy: it’s getting personal
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S by Michael Makris, Michael Leach,
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
Myeloproliferative neoplasms and thrombosis
Survival of children with sickle cell disease
A Novel Risk Assessment Model to Predict Venous Thromboembolism (VTE) in Cancer Inpatients: The Canclot Score by Dana E. Angelini, M. Todd Greene, Julie.
A 41-year-old man with apparent thrombosis of the entire right internal jugular vein (IJV). A 41-year-old man with apparent thrombosis of the entire right.
Cumulative prevalence of venous thromboembolic events in ITP patients who underwent splenectomy compared with those who did not. Cumulative prevalence.
Cold agglutinin disease
New concepts for anticoagulant therapy in persons with hemophilia
DVT = deep vein thrombosis
Elna M. Masuda, MD, Robert L. Kistner, MD, Eugene B. Ferris, MD 
Presentation transcript:

Catheter-related deep venous thrombosis in children with hemophilia by Janna M. Journeycake, Charles T. Quinn, Kim L. Miller, Joy L. Zajac, and George R. Buchanan Blood Volume 98(6):1727-1731 September 15, 2001 ©2001 by American Society of Hematology

Abnormal venogram.Patient 14 had multiple collateral vessels in the right mid-subclavian region providing antegrade flow around the obstruction of the proximal subclavian vein. Abnormal venogram.Patient 14 had multiple collateral vessels in the right mid-subclavian region providing antegrade flow around the obstruction of the proximal subclavian vein. Janna M. Journeycake et al. Blood 2001;98:1727-1731 ©2001 by American Society of Hematology

Probability of remaining free of DVT after the insertion of a CVC. Janna M. Journeycake et al. Blood 2001;98:1727-1731 ©2001 by American Society of Hematology